National Cancer Institute; Notice of Charter Renewal, 83854 [2016-28041]
Download as PDF
<![CDATA[
83854
Federal Register / Vol. 81, No. 225 / Tuesday, November 22, 2016 / Notices
• Electronic responses are preferred
and may be addressed to:
anju.abraham@hhs.gov.
• Written responses should be
addressed to: National Vaccine Program
Office, U.S. Department of Health and
Human Services, 200 Independence
Avenue SW., Room 733G.3B,
Washington, DC 20201, Attn: NVAC
Mid-course Review c/o Anju Abraham.
FOR FURTHER INFORMATION CONTACT:
Anju Abraham, MS, MPH, National
Vaccine Program Office, Office of the
Assistant Secretary for Health,
Department of Health and Human
Services; telephone 202–205–5641;
email anju.abraham@hhs.gov.
SUPPLEMENTARY INFORMATION:
sradovich on DSK3GMQ082PROD with NOTICES
I. Background
Public health represents a
collaboration of multiple sectors in
society working together to prevent
disease and promote health. These
concerted efforts include the
tremendous impacts of the U.S. vaccine
and immunization system, which
represents one of the most significant
public health achievements in the 20th
century. Estimates suggest that routine
childhood immunizations prevented
322 million illnesses and averted
732,000 premature deaths from vaccinepreventable illnesses in children born
between 1994–2013, with an estimated
societal cost-savings of $1.38 trillion.
The 2010 National Vaccine Plan
provides a ten-year strategic direction
for all U.S. vaccine and immunization
related activities to create a robust and
coordinated system to improve the
health of Americans by achieving
optimal prevention of infectious
diseases through vaccination. The
Department of Health and Human
Services recognized the need to conduct
an evaluation of the plan and
subsequently charged the National
Vaccine Advisory Committee with
making recommendations that would
address the progress of the 2010
National Vaccine Plan.
In March 2016, the NVAC formed a
Mid-Course Review Working Group
(MCRWG) to evaluate the status of
progress on the goals of the National
Vaccine Plan (the document can be
found here: www.hhs.gov/nvpo/
national-vaccine-plan/midcourse/
index.html) and develop
recommendations to the ASH. The
MCRWG began their efforts by
reviewing and assessing the findings
from the National Vaccine Program’s
(NVPO) Mid-course Review to identify
the opportunity areas. Then, the
MCRWG shifted its focus to coordinate
additional information collection from
VerDate Sep<11>2014
16:52 Nov 21, 2016
Jkt 241001
non-federal stakeholders to represent
consumer groups and from federal
stakeholders to further inform their
findings and recommendations.
Through a number of conference calls,
electronic communication, and public
discussions at the NVAC meetings, the
working group identified a number of
draft recommendations. These
recommendations frame the five areas
that represent opportunities to advance
the National Vaccine Program over the
remaining five years of the National
Vaccine Plan. These five areas of
opportunity include:
(1) Strengthen health information and
surveillance systems to track, analyze
and visualize disease, immunization
coverage, and safety data, both
domestically and globally;
(2) Foster and facilitate efforts to
strengthen confidence in vaccines and
the immunization system to increase
coverage rates across the lifespan;
(3) Eliminate financial and systems
barriers for providers and consumers to
facilitate access to routinely
recommended vaccines;
(4) Strengthen the science base for the
development and licensure of vaccines;
(5) Facilitate vaccine development.
The NVAC draft report outlines the
background and rationale for each of the
opportunity areas and addresses the
challenges, characteristics that
constitute success, metrics to measure
each area, and proposed metrics to be
developed in the future. The
conclusions and recommendations
detail how the ASH can support HHS
activities in these areas.
II. Request for Comment
NVPO, on behalf of the NVAC Midcourse Review Working Group, requests
input on the draft report and draft
recommendations. In addition to general
comments on the draft report and draft
recommendations, NVPO is seeking
input on characteristics of success,
challenges, and metrics to achieve
success in the five opportunity areas
outlined in the report. Please limit your
comments to six (6) pages.
III. Potential Responders
HHS invites input from a broad range
of stakeholders including individuals
and organizations that have interests
U.S. vaccine and immunization efforts
and the role of HHS in advancing those
efforts.
Examples of potential responders
include, but are not limited to, the
following:
—General public;
—advocacy groups, non-profit
organizations, and public interest
organizations;
PO 00000
Frm 00058
Fmt 4703
Sfmt 9990
—academics, professional societies, and
healthcare organizations;
—public health officials and
immunization program managers;
—physician and non-physician
providers that administer
immunization services, including
pharmacists; and
—representatives from the private
sector.
When responding, please self-identify
with any of the above or other categories
(include all that apply) and your name.
Anonymous submissions will not be
considered. Written submissions should
not exceed six (6) pages. Please do not
send proprietary, commercial, financial,
business, confidential, trade secret, or
personal information.
Dated: November 10, 2016.
Bruce Gellin,
Executive Secretary, National Vaccine
Advisory Committee, Deputy Assistant
Secretary for Health, Director, National
Vaccine Program Office.
[FR Doc. 2016–28090 Filed 11–21–16; 8:45 am]
BILLING CODE 4150–44–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Charter Renewal
In accordance with Title 41 of the
U.S. Code of Federal Regulations,
Section 102–3.65(a), notice is hereby
given that the Charter for the National
Cancer Institute Council of Research
Advocates was renewed for an
additional two-year period on August
17, 2016.
It is determined that the National
Cancer Institute Council of Research
Advocates is in the public interest in
connection with the performance of
duties imposed on the National Cancer
Institute and National Institutes of
Health by law, and that these duties can
best be performed through the advice
and counsel of this group.
Inquiries may be directed to Jennifer
Spaeth, Director, Office of Federal,
Advisory Committee Policy, Office of
the Director, National Institutes of
Health, 6701 Democracy Boulevard,
Suite 1000, Bethesda, Maryland 20892
(Mail code 4875), Telephone (301) 496–
2123, or spaethj@od.nih.gov.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–28041 Filed 11–21–16; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\22NON1.SGM
22NON1
]]>Agencies
[Federal Register Volume 81, Number 225 (Tuesday, November 22, 2016)]
[Notices]
[Page 83854]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-28041]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Charter Renewal
In accordance with Title 41 of the U.S. Code of Federal
Regulations, Section 102-3.65(a), notice is hereby given that the
Charter for the National Cancer Institute Council of Research Advocates
was renewed for an additional two-year period on August 17, 2016.
It is determined that the National Cancer Institute Council of
Research Advocates is in the public interest in connection with the
performance of duties imposed on the National Cancer Institute and
National Institutes of Health by law, and that these duties can best be
performed through the advice and counsel of this group.
Inquiries may be directed to Jennifer Spaeth, Director, Office of
Federal, Advisory Committee Policy, Office of the Director, National
Institutes of Health, 6701 Democracy Boulevard, Suite 1000, Bethesda,
Maryland 20892 (Mail code 4875), Telephone (301) 496-2123, or
spaethj@od.nih.gov.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-28041 Filed 11-21-16; 8:45 am]
BILLING CODE 4140-01-P
